Tania Phillips is a Dermatology physician affiliated with HonorHealth. OpenAlex indexes 218 publications with 11,445 citations (h-index 57); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Albany Street
Shapiro 8
Boston, MA 02118
Telephone
617-638-7420Registry record last updated 20 Dec 2011.
Clinical trials
- A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling
Sponsor: Graceway Pharmaceuticals, LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20241 payment
- Lilly USA, LLCProgram year20241 payment
- Averitas Pharma Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
43.9%Azole Antifungal21.7%Ketoconazole100%Part D≥28 patientsTetracycline-class Drug16.2%Doxycycline Hyclate100%Part D<11 patients+ 1 more class in this area
Sensory organs
23.2%Corticosteroid23.2%Betamethasone Diprop Augmented48%Clobetasol Propionate28%Hydrocortisone24%Part D<11 patientsDermatology
20.7%Corticosteroid20.7%Triamcinolone Acetonide100%Part D≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1991–1999 per NIH RePORTER. The latest:
- BMS-188667 (CTLA4IG) IN PATIENTS WITH PSORIASIS VULGARIS
Boston University Medical Campus
FY1999M01RR000533 - BMS-188667 (CTLA4IG) IN PATIENTS WITH PSORIASIS VULGARIS
Boston University Medical Campus
FY1998M01RR000533 - TREATMENT OF EPIDERMAL ALLOGRAFTS IN THE TREATMENT OF LEG ULCERS
Boston University Medical Campus
FY1991M01RR000533
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pressure ulcers: Pathophysiology, epidemiology, risk factors, and presentation
Journal of the American Academy of Dermatology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Erkut Borazanci, MD, MS
HonorHealth
Zain Khalpey, MD, MRCS
HonorHealth
Venkatesh Ramaiah, MD
HonorHealth
Abraham Kanate, MD
HonorHealth
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”